UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000037308 |
|---|---|
| Receipt number | R000042339 |
| Scientific Title | Observational, prospective study to examine association values of Interferon-Gamma Release Assay (IGRA) before and after treatment and clinical response or adverse events in patients with lung cancer who received cytotoxic cancer chemotherapy containing platinum with or without Immune Checkpoint Inhibitor (ICI) |
| Date of disclosure of the study information | 2019/07/10 |
| Last modified on | 2023/08/01 20:46:28 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2019/07/08 20:13:46 | ||
| 2 | Update | 2019/07/18 08:39:08 | Key inclusion criteria Key inclusion criteria |
|
| 3 | Update | 2019/07/18 08:40:48 | Key inclusion criteria |
|
| 4 | Update | 2019/07/18 08:43:02 | Recruitment status |
|
| 5 | Update | 2021/07/15 13:59:43 | Email Email1 Tel |
|
| 6 | Update | 2021/07/15 14:01:30 | Last follow-up date |
|
| 7 | Update | 2022/01/11 14:58:51 | Recruitment status Last follow-up date |
|
| 8 | Update | 2022/01/11 14:59:29 | Recruitment status |
|
| 9 | Update | 2022/01/11 15:57:49 | Number of participants that the trial has enrolled |
|
| 10 | Update | 2023/07/12 12:52:40 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person Organization Organization Organization Division name Address Address Nationality of Funding Organization |
|
| 11 | Update | 2023/08/01 20:40:08 | UMIN ID1 |
|
| 12 | Update | 2023/08/01 20:46:28 | Email1 |
